Global $10.8 Bn Self-injection Devices Market Trends/Analysis 2022-2030 by Product (Autoinjectors, Needle-free Injectors), Usability (Disposable, Reusable), Application (Cancer, Pain Management) - ResearchAndMarkets.com
Prevention of needlestick injury is a primary factor for healthcare professionals and companies to introduce self-injection devices such as autoinjectors.
- Prevention of needlestick injury is a primary factor for healthcare professionals and companies to introduce self-injection devices such as autoinjectors.
- To avoid needlestick injuries to healthcare workers, the U.S., Europe, and other markets mandate the use of safety devices.
- Significantly, the COVID-19 vaccines will increase the demand for injectable devices and the pandemic has also shown the benefit of self-use devices as well as connected devices.
- North America led the market in 2021 owing to the increasing demand for self-injection devices used for the treatment of several chronic diseases.